Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

"was this included in last years proxy as well or is it new"

Yes, it was.

2
Mar 11, 2013 11:22AM
Share
New Message
Please login to post a reply